Tuesday, November 17, 2026
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEANFastest Growing
Fiinews
No Result
View All Result
Home Exports

Pharma industry told to innovate and self-regulate

Fiinews by Fiinews
November 22, 2018
in Exports, Health, Industry Sectors, Manufacturing
Reading Time: 2 mins read
A A
0
0
SHARES
12
VIEWS
LinkedinShare on Twitter

CII conclave on industry issues

 

 

India’s pharmaceutical sector need to innovate and fix compliance issues through self-regulation to lead in the international markets.

The government and industry need to focus on three key issues, said top executives at a CII Pharma conclave held on 19 Nov 2018.

Better growth in pharmaceutical sector would depend on the ability of companies to fix compliance issues, according to Srini Srinivas, Co-chairman of CII National Committee on Pharmaceuticals and Managing Director of Pfizer Healthcare India.

“If we achieve regulatory capability where mutual recognition of manufacturing in India is accepted globally, it will significantly improve the perception of quality of Indian products, he stressed.

The government and industry need to focus on APIs, innovation and capacity building, said Satish Reddy, Member of CII National Committee on Pharmaceuticals and Chairman of Dr Reddy’s.

On APIs, Dr Reddy said that cluster development must be initiated to ensure survival of industry.

On innovation, he pointed out that low-cost competitiveness was not going to last long.

“New ways of drug discovery had to be found through innovative and out-of-the-box thinking,” he said.

Pharma companies must ensure quality by exercising self-control, exhorted Dr R K Vats, Chairman of National Pharmaceutical Pricing Authority (NPPA) and Additional Secretary & Director General of Central Government Health Scheme.

He urged the industry to maintain parity between the quality of medicines supplied to international markets and those supplied to domestic markets. Quality compliance should come from within, he said.

Dr Vats is also the Managing Director of public sector unit Hindustan Lifecare Limited which is spearheading the government’s programme called Amrit for Affordable Medicines and Reliable Implants for Treatment.

Under this programme, branded high quality drugs, specially life-saving drugs and medical implants and devices are supplied at up to 55% discount on maximum retail price (MRP) through Amrit Pharmacies set up inside government hospitals.

Amrit pharmacies in the country will gradually increase to 1,000 by 2021 from the present 144. The first Amrit Pharmacy was set up three years back at AIIMS in New Delhi.

Speaking at the conclave, Dr Eswara Reddy, Drugs Controller General of India, agreed that India could no longer continue to depend on the past glory of being a generics leader and a supplier to the world.

“Innovation was the need of the hour and it was essential to move beyond the generics,” he said. He urged CII to collaborate with regulators for quality assurance and for improving the capacity of the market. He also called upon CII to set up centres of excellence on drug formulation and development.

The 15th National Pharmaceutical Conclave, organized by the Confederation of Indian Industry (CII) in partnership with the Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers.

CII’s Pharmaceuticals Committee acts as an enabler to foster growth opportunities in the sector. It works on various issues with stakeholders to stay innovation-driven, globally quality-compliant and positions India as a hub for affordable and quality medicines.

The committee has been taking active initiatives on various issues of pharmaceutical industry such as bulk drugs, quality, and ease of doing business. fiinews.com

ShareTweetShare

Related Posts

PIB
Exports

Export: India-Thailand traded $21.49bn in FY25-26

by Fiinews
November 17, 2026
0
22

Thailand presented its “Co-Creation Co-Investment” approach in Nonthaburi The India-Thailand bilateral trade reached USD21.49 billion in FY 2025–26, registering a...

PIB
Exports

Export: India-Egypt set $12bn bilateral trade target

by Fiinews
November 17, 2026
0
18

Ministers discussed trade, supply chains and predictable trade pathways. Minister of Commerce and Industry Piyush Goyal and Dr Mohamed Farid...

Vikram Solar

Manufacture: TN facility to produce from Dec 2026

November 16, 2026
18
ISNT

Manufacture: Minister wants strengthened NDT ecosystem

November 17, 2026
17
Indian Business Porftal

Export: Sustain growth in shipments, says FIOE Chief

November 16, 2026
24
NITI Aayog

Manufacture: PLI successful, says NITI Aayog

November 14, 2026
17
SBI YONO

Recent News

  • Market: HGS-Rackspace to grow in high-value GCCs
  • Tech: DataSwitch’s Mathi automates data mapping
  • Export: India-Thailand traded $21.49bn in FY25-26
  • Export: India-Egypt set $12bn bilateral trade target
  • Manufacture: TN facility to produce from Dec 2026

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY
  • About
  • Advertise
  • Careers
  • Contact us

© 2026 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
  • ASEAN

© 2026 FIINEWS - Design and developed by 7clicksmedia.